Quanterix (QTRX) Net Cash Flow (QoQ) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Quanterix | 165.84 Mn | 66.57 Mn | 15.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 174.89% |
| Dec 31, 2025 | 90.92% |
| Sep 30, 2025 | -268.38% |
| Jun 30, 2025 | 194.17% |
| Mar 31, 2025 | -32.56% |
| Dec 31, 2024 | 255.96% |
| Sep 30, 2024 | -1,163.21% |
| Jun 30, 2024 | 101.32% |
| Mar 31, 2024 | -370.49% |
| Dec 31, 2023 | 78.65% |
| Sep 30, 2023 | -35,611.63% |
| Jun 30, 2023 | 103.84% |
| Mar 31, 2023 | -89.28% |
| Dec 31, 2022 | 72.50% |
| Sep 30, 2022 | -41.69% |
| Jun 30, 2022 | 40.92% |
| Mar 31, 2022 | -64.69% |
| Dec 31, 2021 | 33.96% |
| Sep 30, 2021 | -66.54% |
| Jun 30, 2021 | -104.56% |
| Mar 31, 2021 | 3,070.47% |
| Dec 31, 2020 | -90.23% |
| Sep 30, 2020 | 1,191.29% |
| Jun 30, 2020 | 39.26% |
| Mar 31, 2020 | -192.63% |
| Dec 31, 2019 | -110.53% |
| Sep 30, 2019 | 8.69% |
| Jun 30, 2019 | 464.63% |
| Mar 31, 2019 | -49.24% |
| Dec 31, 2018 | 13.13% |
| Sep 30, 2018 | -69.25% |
| Jun 30, 2018 | 67.08% |
| Mar 31, 2018 | -123.69% |
| Dec 31, 2017 | 902.21% |
| Sep 30, 2017 | -539.48% |
| Jun 30, 2017 | 133.87% |